TCW Group Inc. trimmed its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 7.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,428 shares of the conglomerate's stock after selling 2,309 shares during the period. TCW Group Inc.'s holdings in Danaher were worth $8,182,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in the business. Great Valley Advisor Group Inc. lifted its holdings in shares of Danaher by 11.4% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 1,585 shares of the conglomerate's stock valued at $396,000 after purchasing an additional 162 shares during the last quarter. ORG Partners LLC boosted its holdings in Danaher by 7,633.3% in the second quarter. ORG Partners LLC now owns 464 shares of the conglomerate's stock worth $114,000 after acquiring an additional 458 shares in the last quarter. 4J Wealth Management LLC grew its stake in shares of Danaher by 13.9% during the second quarter. 4J Wealth Management LLC now owns 1,231 shares of the conglomerate's stock worth $308,000 after acquiring an additional 150 shares during the last quarter. Lathrop Investment Management Corp increased its holdings in shares of Danaher by 108.9% during the second quarter. Lathrop Investment Management Corp now owns 22,580 shares of the conglomerate's stock valued at $5,642,000 after acquiring an additional 11,769 shares in the last quarter. Finally, Coronation Fund Managers Ltd. raised its position in shares of Danaher by 29.9% in the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate's stock valued at $1,596,000 after purchasing an additional 1,470 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on DHR. TD Cowen raised their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Stephens restated an "overweight" rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Robert W. Baird lowered their price target on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Finally, Stifel Nicolaus upped their target price on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $287.16.
Read Our Latest Report on Danaher
Danaher Trading Down 0.4 %
NYSE:DHR traded down $0.90 on Thursday, reaching $234.50. 3,988,403 shares of the company's stock were exchanged, compared to its average volume of 2,786,486. The firm has a market capitalization of $169.37 billion, a price-to-earnings ratio of 44.75, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. Danaher Co. has a 52-week low of $219.15 and a 52-week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The business has a fifty day moving average of $248.34 and a 200-day moving average of $257.78.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company's revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period last year, the firm earned $2.02 earnings per share. As a group, analysts expect that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher's dividend payout ratio (DPR) is 20.61%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.